TreeWAS – Variant ID: rs1572050

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
D05.9 Carcinoma in situ of breast, unspecified	0.120	0.880	0.000
D05 Carcinoma in situ of breast	0.095	0.905	0.000
D05.1 Intraductal carcinoma in situ	0.090	0.910	0.000
D05.0 Lobular carcinoma in situ	0.068	0.932	0.000
D05.7 Other carcinoma in situ of breast	0.068	0.932	0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.048	0.952	0.000
C78.7 Secondary malignant neoplasm of liver	0.045	0.955	0.000
C78.2 Secondary malignant neoplasm of pleura	0.045	0.955	0.000
C78.0 Secondary malignant neoplasm of lung	0.044	0.956	0.000
C78.4 Secondary malignant neoplasm of small intestine	0.041	0.959	0.000
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.040	0.960	0.000
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.039	0.961	0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.038	0.962	0.000
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.034	0.966	0.000
C78.1 Secondary malignant neoplasm of mediastinum	0.034	0.966	0.000
A09.9 Gastroenteritis and colitis of unspecified origin	0.000	0.978	0.022
A09 Diarrhoea and gastro-enteritis of presumed infectious origin	0.000	0.980	0.020
A00-A09 Intestinal infectious diseases	0.000	0.982	0.018
A04.7 Enterocolitis due to Clostridium difficile	0.000	0.982	0.018
A08.4 Viral intestinal infection, unspecified	0.000	0.983	0.017
A04 Other bacterial intestinal infections	0.000	0.983	0.017
A08 Viral and other specified intestinal infections	0.000	0.983	0.017
A04.5 Campylobacter enteritis	0.000	0.984	0.016
A09.0 Other and unspecified gastroenteritis and colitis of infectious origin	0.000	0.986	0.014
A06 Amoebiasis	0.000	0.987	0.013
A05 Other bacterial foodborne intoxications	0.000	0.987	0.013
A03 Shigellosis	0.000	0.987	0.013
A01 Typhoid and paratyphoid fevers	0.000	0.987	0.013
A00 Cholera	0.000	0.987	0.013
A04.9 Bacterial intestinal infection, unspecified	0.000	0.987	0.013
A04.6 Enteritis due to Yersinia enterocolitica	0.000	0.987	0.013
A04.4 Other intestinal Escherichia coli infections	0.000	0.987	0.013
A04.3 Enterohaemorrhagic Escherichia coli infection	0.000	0.987	0.013
A04.2 Enteroinvasive Escherichia coli infection	0.000	0.987	0.013
A04.1 Enterotoxigenic Escherichia coli infection	0.000	0.987	0.013
A04.0 Enteropathogenic Escherichia coli infection	0.000	0.987	0.013
A07 Other protozoal intestinal diseases	0.000	0.987	0.013
A08.5 Other specified intestinal infections	0.000	0.987	0.012
A08.3 Other viral enteritis	0.000	0.987	0.012
A08.2 Adenoviral enteritis	0.000	0.987	0.012
A08.0 Rotaviral enteritis	0.000	0.987	0.012
A02 Other Salmonella infections	0.000	0.987	0.012
A08.1 Acute gastro-enteropathy due to Norwalk agent	0.000	0.989	0.011
S52.60 Fracture of lower end of both ulna and radius (closed)	0.010	0.990	0.000
R68.8 Other specified general symptoms and signs	0.010	0.990	0.000
A00.9 Cholera, unspecified	0.000	0.990	0.009
A00.1 Cholera due to Vibrio cholerae 01, biovar el tor	0.000	0.990	0.009
A00.0 Cholera due to Vibrio cholerae 01, biovar cholerae	0.000	0.990	0.009
A01.4 Paratyphoid fever, unspecified	0.000	0.990	0.009
A01.3 Paratyphoid fever C	0.000	0.990	0.009
A01.2 Paratyphoid fever B	0.000	0.990	0.009
A01.1 Paratyphoid fever A	0.000	0.990	0.009
A01.0 Typhoid fever	0.000	0.990	0.009
A03.9 Shigellosis, unspecified	0.000	0.990	0.009
A03.8 Other shigellosis	0.000	0.990	0.009
A03.3 Shigellosis due to Shigella sonnei	0.000	0.990	0.009
A03.2 Shigellosis due to Shigella boydii	0.000	0.990	0.009
A03.1 Shigellosis due to Shigella flexneri	0.000	0.990	0.009
A03.0 Shigellosis due to Shigella dysenteriae	0.000	0.990	0.009
A05.9 Bacterial foodborne intoxication, unspecified	0.000	0.990	0.009
A05.8 Other specified bacterial foodborne intoxications	0.000	0.990	0.009
A05.4 Foodborne Bacillus cereus intoxication	0.000	0.990	0.009
A05.3 Foodborne Vibrio parahaemolyticus intoxication	0.000	0.990	0.009
A05.2 Foodborne Clostridium perfringens [Clostridium welchii] intoxication	0.000	0.990	0.009
A05.1 Botulism	0.000	0.990	0.009
A05.0 Foodborne staphylococcal intoxication	0.000	0.990	0.009
A06.9 Amoebiasis, unspecified	0.000	0.990	0.009
A06.8 Amoebic infection of other sites	0.000	0.990	0.009
A06.7 Cutaneous amoebiasis	0.000	0.990	0.009
A06.6 Amoebic brain abscess	0.000	0.990	0.009
A06.5 Amoebic lung abscess	0.000	0.990	0.009
A06.4 Amoebic liver abscess	0.000	0.990	0.009
A06.3 Amoeboma of intestine	0.000	0.990	0.009
A06.2 Amoebic nondysenteric colitis	0.000	0.990	0.009
A06.1 Chronic intestinal amoebiasis	0.000	0.990	0.009
A06.0 Acute amoebic dysentery	0.000	0.990	0.009
A07.9 Protozoal intestinal disease, unspecified	0.000	0.991	0.009
A07.8 Other specified protozoal intestinal diseases	0.000	0.991	0.009
A07.3 Isosporiasis	0.000	0.991	0.009
A07.2 Cryptosporidiosis	0.000	0.991	0.009
A07.0 Balantidiasis	0.000	0.991	0.009
A02.9 Salmonella infection, unspecified	0.000	0.991	0.009
A02.8 Other specified Salmonella infections	0.000	0.991	0.009
A02.2 Localised Salmonella infections	0.000	0.991	0.009
A02.1 Salmonella septicaemia	0.000	0.991	0.009
A07.1 Giardiasis [lambliasis]	0.000	0.991	0.009
A02.0 Salmonella gastro-enteritis	0.000	0.991	0.009
D00-D09 In situ neoplasms	0.008	0.991	0.000
H02.3 Blepharochalasis	0.008	0.992	0.000
R42 Dizziness and giddiness	0.008	0.992	0.000
Z35.1 Supervision of pregnancy with history of abortive outcome	0.007	0.993	0.000
D09 Carcinoma in situ of other and unspecified sites	0.006	0.993	0.000
S52.6 Fracture of lower end of both ulna and radius	0.006	0.994	0.000
D02 Carcinoma in situ of middle ear and respiratory system	0.006	0.994	0.000
D01 Carcinoma in situ of other and unspecified digestive organs	0.006	0.994	0.000
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.006	0.994	0.000
H02.0 Entropion and trichiasis of eyelid	0.006	0.994	0.000
H02 Other disorders of eyelid	0.006	0.994	0.000
H02.8 Other specified disorders of eyelid	0.006	0.994	0.000
Y43 Primarily systemic agents	0.006	0.994	0.000
H54.7 Unspecified visual loss	0.006	0.994	0.000
Y43.3 Other antineoplastic drugs	0.006	0.994	0.000
O80.9 Single spontaneous delivery, unspecified	0.005	0.994	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.005	0.995	0.000
H02.2 Lagophthalmos	0.005	0.995	0.000
Z35 Supervision of high-risk pregnancy	0.005	0.995	0.000
Z35.0 Supervision of pregnancy with history of infertility	0.005	0.995	0.000
D09.0 Bladder	0.005	0.995	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.005	0.995	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.005	0.995	0.000
Y44 Agents primarily affecting blood constituents	0.005	0.995	0.000
D02.0 Larynx	0.005	0.995	0.000
Y43.4 Immunosuppressive agents	0.005	0.995	0.000
Y43.0 Antiallergic and antiemetic drugs	0.005	0.995	0.000
D09.9 Carcinoma in situ, unspecified	0.005	0.995	0.000
D09.7 Carcinoma in situ of other specified sites	0.005	0.995	0.000
D09.3 Thyroid and other endocrine glands	0.005	0.995	0.000
D09.2 Eye	0.005	0.995	0.000
D09.1 Other and unspecified urinary organs	0.005	0.995	0.000
D03 Melanoma in situ	0.005	0.995	0.000
Y44.2 Anticoagulants	0.005	0.995	0.000
D04 Carcinoma in situ of skin	0.005	0.995	0.000
D02.4 Respiratory system, unspecified	0.005	0.995	0.000
D02.3 Other parts of respiratory system	0.005	0.995	0.000
D02.2 Bronchus and lung	0.005	0.995	0.000
D02.1 Trachea	0.005	0.995	0.000
S52.61 Fracture of lower end of both ulna and radius (open)	0.005	0.995	0.000
D01.9 Digestive organ, unspecified	0.005	0.995	0.000
D01.7 Other specified digestive organs	0.005	0.995	0.000
D01.5 Liver, gallbladder and bile ducts	0.005	0.995	0.000
D01.4 Other and unspecified parts of intestine	0.005	0.995	0.000
D01.3 Anus and anal canal	0.005	0.995	0.000
D01.2 Rectum	0.005	0.995	0.000
D01.1 Rectosigmoid junction	0.005	0.995	0.000
D01.0 Colon	0.005	0.995	0.000
Z35.8 Supervision of other high-risk pregnancies	0.005	0.995	0.000
D00.2 Stomach	0.005	0.995	0.000
D00.1 Oesophagus	0.005	0.995	0.000
Y40 Systemic antibiotics	0.005	0.995	0.000
D00.0 Lip, oral cavity and pharynx	0.004	0.995	0.000
Y48 Anaesthetics and therapeutic gases	0.005	0.995	0.000
H02.7 Other degenerative disorders of eyelid and periocular area	0.004	0.995	0.000
H54 Blindness and low vision	0.005	0.995	0.000
H54.0 Blindness, both eyes	0.005	0.995	0.000
D06 Carcinoma in situ of cervix uteri	0.004	0.995	0.000
H02.1 Ectropion of eyelid	0.004	0.995	0.000
Z11.0 Special screening examination for intestinal infectious diseases	0.000	0.995	0.005
Y45.2 Propionic acid derivatives	0.004	0.996	0.000
Z35.9 Supervision of high-risk pregnancy, unspecified	0.004	0.996	0.000
Y43.9 Primarily systemic agent, unspecified	0.004	0.996	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.004	0.996	0.000
Y43.6 Enzymes, not elsewhere classified	0.004	0.996	0.000
Y43.5 Acidifying and alkalising agents	0.004	0.996	0.000
Y43.2 Antineoplastic natural products	0.004	0.996	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.004	0.996	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.004	0.996	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.004	0.996	0.000
H02.5 Other disorders affecting eyelid function	0.004	0.996	0.000
Y40.3 Macrolides	0.004	0.996	0.000
Y57 Other and unspecified drugs and medicaments	0.004	0.996	0.000
H02.6 Xanthelasma of eyelid	0.004	0.996	0.000
Y43.1 Antineoplastic antimetabolites	0.004	0.996	0.000
D07 Carcinoma in situ of other and unspecified genital organs	0.004	0.996	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.004	0.996	0.000
Y48.3 Local anaesthetics	0.004	0.996	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.004	0.996	0.000
Y59 Other and unspecified vaccines and biological substances	0.004	0.996	0.000
Y58 Bacterial vaccines	0.004	0.996	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.004	0.996	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.004	0.996	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.004	0.996	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.004	0.996	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
Y40.8 Other systemic antibiotics	0.004	0.996	0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.004	0.996	0.000
Z35.7 Supervision of high-risk pregnancy due to social problems	0.004	0.996	0.000
Z35.6 Supervision of very young primigravida	0.004	0.996	0.000
Z35.4 Supervision of pregnancy with grand multiparity	0.004	0.996	0.000
Z35.3 Supervision of pregnancy with history of insufficient antenatal care	0.004	0.996	0.000
D03.4 Melanoma in situ of scalp and neck	0.004	0.996	0.000
O80 Single spontaneous delivery	0.004	0.996	0.000
C61 Malignant neoplasm of prostate	0.000	0.996	0.004
Y40.9 Systemic antibiotic, unspecified	0.004	0.996	0.000
D04.7 Skin of lower limb, including hip	0.004	0.996	0.000
D03.6 Melanoma in situ of upper limb, including shoulder	0.004	0.996	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.004	0.996	0.000
Y44.7 Plasma substitutes	0.004	0.996	0.000
Y44.6 Natural blood and blood products	0.004	0.996	0.000
Y44.5 Thrombolytic drugs	0.004	0.996	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.004	0.996	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.004	0.996	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.004	0.996	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.004	0.996	0.000
Y45.8 Other analgesics and antipyretics	0.004	0.996	0.000
Y45.5 4-Aminophenol derivatives	0.004	0.996	0.000
Y45.4 Antirheumatics	0.004	0.996	0.000
Y57.5 X-ray contrast media	0.004	0.996	0.000
D03.7 Melanoma in situ of lower limb, including hip	0.004	0.996	0.000
D04.6 Skin of upper limb, including shoulder	0.004	0.996	0.000
D03.9 Melanoma in situ, unspecified	0.004	0.996	0.000
D03.8 Melanoma in situ of other sites	0.004	0.996	0.000
D03.2 Melanoma in situ of ear and external auricular canal	0.004	0.996	0.000
D03.1 Melanoma in situ of eyelid, including canthus	0.004	0.996	0.000
D03.0 Melanoma in situ of lip	0.004	0.996	0.000
D04.9 Skin, unspecified	0.004	0.996	0.000
D04.8 Skin of other sites	0.004	0.996	0.000
D04.4 Skin of scalp and neck	0.004	0.996	0.000
D04.2 Skin of ear and external auricular canal	0.004	0.996	0.000
D04.1 Skin of eyelid, including canthus	0.004	0.996	0.000
D04.0 Skin of lip	0.004	0.996	0.000
H54.9 Unspecified visual impairment (binocular)	0.004	0.996	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.003	0.996	0.001
Y53.1 Other antacids and anti-gastric-secretion drugs	0.004	0.996	0.000
S51.8 Open wound of other parts of forearm	0.004	0.996	0.000
Y46.4 Iminostilbenes	0.004	0.996	0.000
Y40.7 Antifungal antibiotics, systemically used	0.004	0.996	0.000
Y40.6 Rifamycins	0.004	0.996	0.000
Y40.5 Aminoglycosides	0.004	0.996	0.000
Y40.4 Tetracyclines	0.004	0.996	0.000
Y40.2 Chloramphenicol group	0.004	0.996	0.000
Y45.0 Opioids and related analgesics	0.004	0.996	0.000
I31.3 Pericardial effusion (noninflammatory)	0.000	0.996	0.004
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.004	0.996	0.000
Y52 Agents primarily affecting the cardiovascular system	0.004	0.996	0.000
Y48.5 Therapeutic gases	0.003	0.996	0.000
Y48.4 Anaesthetic, unspecified	0.003	0.996	0.000
Y48.2 Other and unspecified general anaesthetics	0.003	0.996	0.000
Y48.1 Parenteral anaesthetics	0.003	0.996	0.000
Y48.0 Inhaled anaesthetics	0.003	0.996	0.000
S52 Fracture of forearm	0.004	0.996	0.000
H54.6 Unqualified visual loss, one eye	0.003	0.996	0.000
H54.5 Low vision, one eye	0.003	0.996	0.000
H54.3 Unqualified visual loss, both eyes	0.003	0.996	0.000
H54.2 Low vision, both eyes	0.003	0.996	0.000
H54.1 Blindness, one eye, low vision, other eye	0.003	0.996	0.000
Y53.4 Other laxatives	0.003	0.996	0.000
D06.7 Other parts of cervix	0.003	0.996	0.000
D06.1 Exocervix	0.003	0.996	0.000
D06.0 Endocervix	0.003	0.996	0.000
Y54.8 Agents affecting uric acid metabolism	0.003	0.996	0.000
Y57.8 Other drugs and medicaments	0.003	0.997	0.000
H54.4 Blindness, one eye	0.003	0.997	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.003	0.997	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
Y53.7 Emetics	0.003	0.997	0.000
Y53.6 Antidiarrhoeal drugs	0.003	0.997	0.000
Y53.5 Digestants	0.003	0.997	0.000
Y53.3 Saline and osmotic laxatives	0.003	0.997	0.000
Y53.2 Stimulant laxatives	0.003	0.997	0.000
Y53.0 Histamine H2-receptor antagonists	0.003	0.997	0.000
Z35.2 Supervision of pregnancy with other poor reproductive or obstetric history	0.003	0.997	0.000
O80.0 Spontaneous vertex delivery	0.003	0.997	0.000
Y46.8 Antispasticity drugs	0.003	0.997	0.000
Y46.7 Anti-Parkinsonism drugs	0.003	0.997	0.000
Y46.6 Other and unspecified antiepileptics	0.003	0.997	0.000
Y46.5 Valproic acid	0.003	0.997	0.000
Y46.3 Deoxybarbiturates	0.003	0.997	0.000
Y46.2 Hydantoin derivatives	0.003	0.997	0.000
Y46.1 Oxazolidinediones	0.003	0.997	0.000
Y46.0 Succinimides	0.003	0.997	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.997	0.000
Y41.5 Antiviral drugs	0.003	0.997	0.000
Y41.4 Anthelminthics	0.003	0.997	0.000
Y41.3 Other antiprotozoal drugs	0.003	0.997	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.997	0.000
Y41.1 Antimycobacterial drugs	0.003	0.997	0.000
Y41.0 Sulphonamides	0.003	0.997	0.000
O80.8 Other single spontaneous delivery	0.003	0.997	0.000
S51 Open wound of forearm	0.003	0.997	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.003	0.997	0.000
Y57.7 Vitamins, not elsewhere classified	0.003	0.997	0.000
Y57.6 Other diagnostic agents	0.003	0.997	0.000
Y57.4 Pharmaceutical excipients	0.003	0.997	0.000
Y57.3 Alcohol deterrents	0.003	0.997	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
Y57.1 Lipotropic drugs	0.003	0.997	0.000
Y57.0 Appetite depressants [anorectics]	0.003	0.997	0.000
D07.4 Penis	0.003	0.997	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.003	0.997	0.000
D07.6 Other and unspecified male genital organs	0.003	0.997	0.000
D07.3 Other and unspecified female genital organs	0.003	0.997	0.000
D07.2 Vagina	0.003	0.997	0.000
D07.0 Endometrium	0.003	0.997	0.000
C76 Malignant neoplasm of other and ill-defined sites	0.003	0.997	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.997	0.000
Y56.9 Topical agent, unspecified	0.003	0.997	0.000
Y56.8 Other topical agents	0.003	0.997	0.000
Y56.7 Dental drugs, topically applied	0.003	0.997	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
Y56.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
Y56.3 Emollients, demulcents and protectants	0.003	0.997	0.000
Y56.2 Local astringents and local detergents	0.003	0.997	0.000
Y56.1 Antipruritics	0.003	0.997	0.000
D04.5 Skin of trunk	0.003	0.997	0.000
S52.0 Fracture of upper end of ulna	0.003	0.997	0.000
Y50.9 Central nervous system stimulant, unspecified	0.003	0.997	0.000
Y50.8 Other central nervous system stimulants	0.003	0.997	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.003	0.997	0.000
Y50.1 Opioid receptor antagonists	0.003	0.997	0.000
Y50.0 Analeptics	0.003	0.997	0.000
Y54.9 Mineral salts, not elsewhere classified	0.003	0.997	0.000
Y54.7 Agents affecting calcification	0.003	0.997	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.003	0.997	0.000
Y54.4 Loop [high-ceiling] diuretics	0.003	0.997	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.003	0.997	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.003	0.997	0.000
Y54.0 Mineralocorticoids	0.003	0.997	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.997	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.003	0.997	0.000
Y55.5 Anticommon cold drugs	0.003	0.997	0.000
Y55.4 Expectorants	0.003	0.997	0.000
Y55.3 Antitussives	0.003	0.997	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.003	0.997	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.997	0.000
Y55.0 Oxytocic drugs	0.003	0.997	0.000
Y58.9 Other and unspecified bacterial vaccines	0.003	0.997	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.003	0.997	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.003	0.997	0.000
Y58.5 Diphtheria vaccine	0.003	0.997	0.000
Y58.4 Tetanus vaccine	0.003	0.997	0.000
Y58.3 Plague vaccine	0.003	0.997	0.000
Y58.2 Cholera vaccine	0.003	0.997	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.003	0.997	0.000
Y58.0 BCG vaccine	0.003	0.997	0.000
Y59.9 Vaccine or biological substance, unspecified	0.003	0.997	0.000
Y59.8 Other specified vaccines and biological substances	0.003	0.997	0.000
Y59.3 Immunoglobulin	0.003	0.997	0.000
Y59.2 Protozoal vaccines	0.003	0.997	0.000
Y59.1 Rickettsial vaccines	0.003	0.997	0.000
Y59.0 Viral vaccines	0.003	0.997	0.000
R68 Other general symptoms and signs	0.003	0.997	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.003	0.997	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.003	0.997	0.000
Y47.4 Bromine compounds	0.003	0.997	0.000
Y47.3 Paraldehyde	0.003	0.997	0.000
Y47.2 Chloral derivatives	0.003	0.997	0.000
Y47.0 Barbiturates, not elsewhere classified	0.003	0.997	0.000
Y49.9 Psychotropic drug, unspecified	0.003	0.997	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
Y49.7 Psychostimulants with abuse potential	0.003	0.997	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.003	0.997	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.997	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.003	0.997	0.000
Y49.2 Other and unspecified antidepressants	0.003	0.997	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.997	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.003	0.997	0.000
Y47.1 Benzodiazepines	0.003	0.997	0.000
Z35.5 Supervision of elderly primigravida	0.003	0.997	0.000
S52.00 Fracture of upper end of ulna (closed)	0.003	0.997	0.000
O80.1 Spontaneous breech delivery	0.003	0.997	0.000
Y49.5 Other antipsychotics and neuroleptics	0.003	0.997	0.000
S51.0 Open wound of elbow	0.003	0.997	0.000
Y54.3 Benzothiadiazine derivatives	0.003	0.997	0.000
R59.9 Enlarged lymph nodes, unspecified	0.003	0.997	0.000
D03.3 Melanoma in situ of other and unspecified parts of face	0.003	0.997	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.002	0.997	0.001
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.997	0.001
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.997	0.001
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.997	0.001
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.997	0.001
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.997	0.001
Y51.1 Other parasympathomimetics [cholinergics]	0.002	0.997	0.001
Y51.0 Anticholinesterase agents	0.002	0.997	0.001
S52.2 Fracture of shaft of ulna	0.003	0.997	0.000
Y40.0 Penicillins	0.003	0.997	0.000
D63.0 Anaemia in neoplastic disease	0.003	0.997	0.000
S52.3 Fracture of shaft of radius	0.003	0.997	0.000
S50-S59 Injuries to the elbow and forearm	0.003	0.997	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
Y52.7 Peripheral vasodilators	0.003	0.997	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
C76.1 Thorax	0.003	0.997	0.000
D07.1 Vulva	0.002	0.997	0.000
S52.9 Fracture of forearm, part unspecified	0.003	0.997	0.000
Y52.1 Calcium-channel blockers	0.003	0.997	0.000
Y54.5 Other diuretics	0.003	0.997	0.000
D03.5 Melanoma in situ of trunk	0.003	0.997	0.000
D04.3 Skin of other and unspecified parts of face	0.003	0.997	0.000
S52.4 Fracture of shafts of both ulna and radius	0.003	0.997	0.000
F40.2 Specific (isolated) phobias	0.003	0.997	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
H02.4 Ptosis of eyelid	0.003	0.997	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
S51.7 Multiple open wounds of forearm	0.003	0.997	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
R59.0 Localised enlarged lymph nodes	0.003	0.997	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
Y57.9 Drug or medicament, unspecified	0.002	0.997	0.000
C76.8 Overlapping lesion of other and ill-defined sites	0.002	0.997	0.000
C76.7 Other ill-defined sites	0.002	0.997	0.000
C76.5 Lower limb	0.002	0.997	0.000
C76.4 Upper limb	0.002	0.997	0.000
C76.3 Pelvis	0.002	0.997	0.000
C76.2 Abdomen	0.002	0.997	0.000
I44.2 Atrioventricular block, complete	0.003	0.997	0.000
S56 Injury of muscle and tendon at forearm level	0.003	0.997	0.000
R68.3 Clubbing of fingers	0.002	0.997	0.000
R68.2 Dry mouth, unspecified	0.002	0.997	0.000
R68.1 Nonspecific symptoms peculiar to infancy	0.002	0.997	0.000
S52.7 Multiple fractures of forearm	0.002	0.997	0.000
H00-H06 Disorders of eyelid, lacrimal system and orbit	0.003	0.997	0.000
C76.0 Head, face and neck	0.002	0.997	0.000
S52.8 Fracture of other parts of forearm	0.002	0.997	0.000
S70.9 Superficial injury of hip and thigh, unspecified	0.000	0.998	0.002
S51.9 Open wound of forearm, part unspecified	0.002	0.998	0.000
S52.01 Fracture of upper end of ulna (open)	0.002	0.998	0.000
S52.20 Fracture of shaft of ulna (closed)	0.002	0.998	0.000
H01.0 Blepharitis	0.002	0.998	0.000
S53 Dislocation, sprain and strain of joints and ligaments of elbow	0.002	0.998	0.000
S52.30 Fracture of shaft of radius (closed)	0.002	0.998	0.000
H06 Disorders of lachrymal system and orbit in diseases classified elsewhere	0.002	0.998	0.000
C77.8 Lymph nodes of multiple regions	0.002	0.998	0.000
Y45.1 Salicylates	0.002	0.998	0.001
D69.3 Idiopathic thrombocytopenic purpura	0.000	0.998	0.002
S52.21 Fracture of shaft of ulna (open)	0.002	0.998	0.000
S52.31 Fracture of shaft of radius (open)	0.002	0.998	0.000
H01 Other inflammation of eyelid	0.002	0.998	0.000
S58 Traumatic amputation of forearm	0.002	0.998	0.000
S57 Crushing injury of forearm	0.002	0.998	0.000
S55 Injury of blood vessels at forearm level	0.002	0.998	0.000
S54 Injury of nerves at forearm level	0.002	0.998	0.000
C77.4 Inguinal and lower limb lymph nodes	0.002	0.998	0.000
S52.1 Fracture of upper end of radius	0.002	0.998	0.000
S56.4 Injury of extensor muscle and tendon of other finger(s) at forearm level	0.002	0.998	0.000
S52.41 Fracture of shafts of both ulna and radius (open)	0.002	0.998	0.000
S52.91 Fracture of forearm, part unspecified (open)	0.002	0.998	0.000
S52.90 Fracture of forearm, part unspecified (closed)	0.002	0.998	0.000
H06.2 Dysthyroid exophthalmos	0.002	0.998	0.000
S52.40 Fracture of shafts of both ulna and radius (closed)	0.002	0.998	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.001	0.998	0.002
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.002	0.998	0.000
S66.1 Injury of flexor muscle and tendon of other finger at wrist and hand level	0.000	0.998	0.002
Y42.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
Y42.4 Oral contraceptives	0.002	0.998	0.000
Y42.2 Antithyroid drugs	0.002	0.998	0.000
Y42.1 Thyroid hormones and substitutes	0.002	0.998	0.000
Q85.0 Neurofibromatosis (nonmalignant)	0.002	0.998	0.000
S59 Other and unspecified injuries of forearm	0.002	0.998	0.000
S56.8 Injury of other and unspecified muscles and tendons at forearm level	0.002	0.998	0.000
H00 Hordeolum and chalazion	0.002	0.998	0.000
R59 Enlarged lymph nodes	0.002	0.998	0.000
K40.3 Unilateral or unspecified inguinal hernia, with obstruction, without gangrene	0.002	0.998	0.000
S50 Superficial injury of forearm	0.002	0.998	0.000
S56.2 Injury of other flexor muscle and tendon at forearm level	0.002	0.998	0.000
S56.7 Injury of multiple muscles and tendons at forearm level	0.002	0.998	0.000
S56.5 Injury of other extensor muscle and tendon at forearm level	0.002	0.998	0.000
S56.3 Injury of extensor or abductor muscles and tendons of thumb at forearm level	0.002	0.998	0.000
S56.1 Injury of flexor muscle and tendon of other finger(s) at forearm level	0.002	0.998	0.000
S56.0 Injury of flexor muscle and tendon of thumb at forearm level	0.002	0.998	0.000
S52.71 Multiple fractures of forearm (open)	0.002	0.998	0.000
H00.0 Hordeolum and other deep inflammation of eyelid	0.002	0.998	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
H03 Disorders of eyelid in diseases classified elsewhere	0.002	0.998	0.000
R40-R46 Symptoms and signs involving cognition, perception, emotional state and behaviour	0.002	0.998	0.000
R68.0 Hypothermia, not associated with low environmental temperature	0.002	0.998	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
S02.60 Fracture of mandible (closed)	0.002	0.998	0.000
S52.81 Fracture of other parts of forearm (open)	0.002	0.998	0.000
F32.0 Mild depressive episode	0.002	0.998	0.000
S53.3 Traumatic rupture of ulnar collateral ligament	0.002	0.998	0.000
R46 Symptoms and signs involving appearance and behaviour	0.002	0.998	0.000
R46.8 Other symptoms and signs involving appearance and behaviour	0.002	0.998	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
H06.3 Other disorders of orbit in diseases classified elsewhere	0.002	0.998	0.000
H06.1 Parasitic infestation of orbit in diseases classified elsewhere	0.002	0.998	0.000
H06.0 Disorders of lachrymal system in diseases classified elsewhere	0.002	0.998	0.000
S53.1 Dislocation of elbow, unspecified	0.002	0.998	0.000
S53.4 Sprain and strain of elbow	0.002	0.998	0.000
S53.2 Traumatic rupture of radial collateral ligament	0.002	0.998	0.000
S53.0 Dislocation of radial head	0.002	0.998	0.000
S70.0 Contusion of hip	0.000	0.998	0.002
D07.5 Prostate	0.001	0.998	0.001
H01.9 Inflammation of eyelid, unspecified	0.002	0.998	0.000
H01.1 Non-infectious dermatoses of eyelid	0.002	0.998	0.000
S52.11 Fracture of upper end of radius (open)	0.002	0.998	0.000
S54.2 Injury of radial nerve at forearm level	0.002	0.998	0.000
S54.9 Injury of unspecified nerve at forearm level	0.002	0.998	0.000
S54.8 Injury of other nerves at forearm level	0.002	0.998	0.000
S54.7 Injury of multiple nerves at forearm level	0.002	0.998	0.000
S54.3 Injury of cutaneous sensory nerve at forearm level	0.002	0.998	0.000
S54.1 Injury of median nerve at forearm level	0.002	0.998	0.000
S54.0 Injury of ulnar nerve at forearm level	0.002	0.998	0.000
S55.9 Injury of unspecified blood vessel at forearm level	0.002	0.998	0.000
S55.8 Injury of other blood vessels at forearm level	0.002	0.998	0.000
S55.7 Injury of multiple blood vessels at forearm level	0.002	0.998	0.000
S55.2 Injury of vein at forearm level	0.002	0.998	0.000
S55.1 Injury of radial artery at forearm level	0.002	0.998	0.000
S55.0 Injury of ulnar artery at forearm level	0.002	0.998	0.000
S57.9 Crushing injury of forearm, part unspecified	0.002	0.998	0.000
S57.8 Crushing injury of forearm, part unspecified	0.002	0.998	0.000
S57.7 Crushing injury of other parts of forearm	0.002	0.998	0.000
S57.0 Crushing injury of elbow	0.002	0.998	0.000
S58.9 Traumatic amputation of forearm, level unspecified	0.002	0.998	0.000
S58.1 Traumatic amputation at level between elbow and wrist	0.002	0.998	0.000
S58.0 Traumatic amputation at elbow level	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations